2024-11-19 05:55:17
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)
Corporate/ 2023-07-23
CStone and EQRx Enter Global Strategic P...

CStone to out-license to EQRx exclusive rights to two late-stage immuno-oncology assets for development and commercialization outside of Gre...

Drawbridge Health Announces Partnerships to Fuel Expansion in Japan
Health/ 2023-07-22
Drawbridge Health Announces Partnerships...

MENLO PARK,Calif.,Oct. 27,2020--Drawbridge Health,a healthcare technology company redefining the blood draw experience for both patients and...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release